UNSPSC 51392209: Dexlofexidine or levlofexidine or lofexidine

This classification denotes an alpha-adrenergic agonist with the molecular formula C11H12Cl2N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5SPW497X0Z, chemically known as (-)-(r)-2-(1-(2,6-dichlorophenoxy)ethyl)-2-imidazoline. but generally known as levlofexidine, which bears US NIH Compound Identifier 3038503. European Medicines Agency schedules Levlofexidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08461MIG.

The term LEVLOFEXIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). LEVLOFEXIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: CC(C1=NCCN1)OC2=C(C=CC=C2Cl)Cl.

UNSPSC 51392209 Dexlofexidine or levlofexidine or lofexidine (Commodity) represents opioid-antagonist medications and related pharmaceutical products, though recent state and local procurement activity under this code shows little alignment with the nominal commodity scope. The single recent opportunity identified—Seminole County, Florida's IFB60459723LAS for naloxone and drug deactivation systems—targets naloxone procurement as a community health intervention rather than the specific active pharmaceutical ingredients named in the code. State and local governments soliciting under UNSPSC 51392209 appear to include county health departments and community health agencies pursuing opioid-response initiatives, though the recent-opportunities block reflects minimal activity under this specific code designation.

Seminole County, Florida posted the primary recent opportunity on June 30, 2026, with a response deadline of July 26, 2023 (the source date contains an apparent inconsistency). The county sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive sealed bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The IFB required unit pricing for each line item, E-Verify compliance, standard insurance coverage (workers' compensation, commercial general liability, professional liability), and drug-free workplace certification. The contract structure included a two-year initial term with a one-year renewal option and a three-month probationary period allowing termination for cause or without cause. Potential FEMA funding introduced additional federal compliance obligations including the Clean Air Act and Federal Water Pollution Control Act. The recent-opportunities block shows no other state or local solicitations under this code, indicating limited current procurement activity at the state and local level under this commodity designation.